Molecular biology of the androgen receptor

被引:736
作者
Gelmann, EP [1 ]
机构
[1] Georgetown Univ, Dept Oncol, Lombardi Canc Ctr, Sch Med, Washington, DC 20007 USA
关键词
D O I
10.1200/JCO.2002.10.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Androgen receptor (AR) is a member of the steroid hormone receptor family of molecules. AR primarily is responsible for mediating the physiologic effects of androgens by binding to specific DNA sequences that influence transcription of androgenresponsive genes. The three-dimensional structure of the AR ligand-binding domain has shown it is similar to other steroid hormone receptors and that ligand binding alters the protein conformation to allow binding of coactivator molecules that amplify the hormone signal and mediate transcriptional initiation. However, AR also undergoes intramolecular interactions that regulate its interactions with coactivators and influence its activity. A large number of naturally occurring mutations of the human AR gene have provided important information about AR molecular structure and intermolecular interactions. AR is also a critical mediator of prostate cancer promotion, conferring growth signals to prostate cancer cells throughout the natural history of the disease. Late-stage prostate cancer, unresponsive to hormonal deprivation, sustains AR signaling through a diverse array of molecular strategies. Variations in the AR gene may also confer genetic predisposition to prostate cancer development and severity. Further understanding of AR action and new strategies to interfere with AR signaling hold promise for improving prostate cancer therapy. (C) 2002 by American Society of Clinical Oncology.
引用
收藏
页码:3001 / 3015
页数:15
相关论文
共 195 条
  • [1] CREB-binding protein in androgen receptor-mediated signaling
    Aarnisalo, P
    Palvimo, JJ
    Jänne, OA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) : 2122 - 2127
  • [2] Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice
    Abel, A
    Walcott, J
    Woods, J
    Duda, J
    Merry, DE
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (02) : 107 - 116
  • [3] Androgen-insensitivity syndrome as a possible coactivator disease
    Adachi, M
    Takayanagi, R
    Tomura, A
    Imasaki, K
    Kato, S
    Goto, K
    Yanase, T
    Ikuyama, S
    Nawata, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (12) : 856 - 862
  • [4] THE STRINGENCY AND MAGNITUDE OF ANDROGEN-SPECIFIC GENE ACTIVATION ARE COMBINATORIAL FUNCTIONS OF RECEPTOR AND NONRECEPTOR BINDING-SITE SEQUENCES
    ADLER, AJ
    SCHELLER, A
    ROBINS, DM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) : 6326 - 6335
  • [5] ANDROGEN-SPECIFIC GENE ACTIVATION VIA A CONSENSUS GLUCOCORTICOID RESPONSE ELEMENT IS DETERMINED BY INTERACTION WITH NONRECEPTOR FACTORS
    ADLER, AJ
    DANIELSEN, M
    ROBINS, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) : 11660 - 11663
  • [6] AHLUWALIA B, 1981, CANCER, V48, P2267, DOI 10.1002/1097-0142(19811115)48:10<2267::AID-CNCR2820481023>3.0.CO
  • [7] 2-R
  • [8] Alen P, 1999, MOL CELL BIOL, V19, P6085
  • [9] THE RAT ANDROGEN RECEPTOR GENE PROMOTER
    BAARENDS, WM
    THEMMEN, APN
    BLOK, LJ
    MACKENBACH, P
    BRINKMANN, AO
    MEIJER, D
    FABER, PW
    TRAPMAN, J
    GROOTEGOED, JA
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 74 (01) : 75 - 84
  • [10] INTERACTION OF HUMAN THYROID-HORMONE RECEPTOR-BETA WITH TRANSCRIPTION FACTOR TFIIB MAY MEDIATE TARGET GENE DEREPRESSION AND ACTIVATION BY THYROID-HORMONE
    BANIAHMAD, A
    HA, I
    REINBERG, D
    TSAI, S
    TSAI, MJ
    OMALLEY, BW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) : 8832 - 8836